实施和评估贝叶斯响应适应性随机化,用于剂量检测试验中的回填
Lukas Pin1, Sofía S Villar1, Hakim-Moulay Dehbi2
1MRC Biostatistics Unit at University of Cambridge, Cambridge, UK.
Contemporary clinical trials
|May 10, 2024
概括
这项研究引入了以患者为中心的补充方法,用于早期临床试验的贝叶斯响应适应性随机化. 这种方法通过将患者分配到更有效的剂量水平来改善确定最佳剂量的方法,从而提高试验结果.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的剂量检测试验优先考虑最大耐受剂量.
- 早期瘤学试验越来越多地旨在平衡疗效和耐受性.
- 补充试验可以收集关键数据来选择剂量.
研究的目的:
- 提出一个以患者为导向的补充策略,使用贝叶斯反应适应性随机化.
- 加强在早期临床试验中确定最佳剂量水平.
- 为设计和分析以患者为导向的补充提供一个框架.
主要方法:
- 使用贝叶斯响应适应性随机化来在回填集中分配患者.
- 根据新出现的数据,动态地将患者分配到具有更高预期疗效的剂量水平.
- 模拟不同的临床试验环境来评估拟议的策略.
主要成果:
- 拟议的补充策略表明了以患者为导向的方法.
- 贝叶斯响应适应性随机化增强了对最佳剂量水平的准确识别.
- 模拟证实了该策略在各种试验环境中的有效性.
结论:
- 以贝叶斯反应适应性随机化为患者导向的补充对早期阶段试验有效.
- 这种方法可以更好地为后续研究选择最合适的剂量.
- 该研究为实施这种创新的试验设计提供了实际框架.
更多相关视频
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.8K
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
相关概念视频
01:13Randomized Experiments
6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
01:03Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
01:25Strategies for Assessing and Addressing Confounding
93
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
93
01:22Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K